ストックスクリーナーアプリを入手
0.8033
2.57%
-0.0212
アフターアワーズ：
.80
-0.0033
-0.41%
前日終値:
$0.8245
開ける：
$0.8051
24時間の取引高:
84,844
Relative Volume:
0.01
時価総額：
$8.46M
収益：
$1.78M
当期純損益:
$-58.35M
株価収益率:
-0.4898
EPS:
-1.64
ネットキャッシュフロー:
$-56.66M
1週間 パフォーマンス:
-7.34%
1か月 パフォーマンス:
-22.76%
6か月 パフォーマンス:
-64.46%
1年 パフォーマンス:
+218.90%
1日の値動き範囲:
$0.793
$0.8257
1週間の範囲:
$0.7576
$0.8706
52週間の値動き範囲:
$0.1521
$4.78
Beyond Air Inc Stock (XAIR) Company Profile
Compare XAIR vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XAIR
Beyond Air Inc
|
0.8033 | 8.68M | 1.78M | -58.35M | -56.66M | -1.64 |
|
ABT
Abbott Laboratories
|
110.25 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
345.78 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
88.97 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.63 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.09 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Beyond Air Inc Stock (XAIR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-17 | 開始されました | D. Boral Capital | Buy |
| 2024-06-25 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-07-28 | 開始されました | Piper Sandler | Overweight |
| 2023-06-15 | 開始されました | BTIG Research | Buy |
| 2021-04-28 | 開始されました | Truist | Buy |
| 2019-10-22 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Beyond Air Inc (XAIR) 最新ニュース
Beyond Air to Participate in the 38th Annual Roth Conference in March - The Manila Times
Beyond Air to Participate in the 38th Annual Roth Conference in March - GlobeNewswire Inc.
Beyond Air terminates NeuroNOS sale talks with XTL Biopharmaceuticals By Investing.com - Investing.com Canada
Beyond Air terminates NeuroNOS sale talks with XTL Biopharmaceuticals - Investing.com South Africa
Beyond Air (XAIR) Buy Rating Reaffirmed by D. Boral Capital | XA - GuruFocus
Beyond Air Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd. - Bitget
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd. - The Manila Times
Beyond Air drops NeuroNOS sale, rethinks neurological and cancer plans - Stock Titan
XTL Biopharmaceuticals Ltd. cancelled the acquisition of 85% stake in NeuroNos Limited from Beyond Air, Inc.. - marketscreener.com
New Highs: Is Beyond Air Inc stock a falling knife or bargain buy2025 Biggest Moves & Verified Momentum Stock Watchlist - baoquankhu1.vn
Technical Analysis: Can Beyond Air Inc continue delivering strong returns2025 Risk Factors & Verified Short-Term Trading Plans - baoquankhu1.vn
Insider Sell: Will Beyond Air Inc benefit from geopolitical trends2025 Short Interest & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Swing Trade: Is Beyond Air Inc stock a buy or sellWeekly Trading Summary & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Beyond Air Inc (XAIR) Expands Focus on Nitric Oxide Therapies - Finviz
12 Best NASDAQ Penny Stocks to Buy According to Analysts - Insider Monkey
Published on: 2026-03-02 20:03:07 - baoquankhu1.vn
Bull Bear: Can Beyond Air Inc deliver consistent EPS growthJuly 2025 Setups & Stock Portfolio Risk Management - baoquankhu1.vn
XAIR Should I Buy - Intellectia AI
XAIR PE Ratio & Valuation, Is XAIR Overvalued - Intellectia AI
How The Narrative On Beyond Air (XAIR) Is Resetting Around LungFit PH And Delayed Approval - Yahoo Finance
Earnings Beat: What is the PEG ratio of Beyond Air IncJuly 2025 Final Week & Real-Time Chart Pattern Alerts - baoquankhu1.vn
XAIR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Beyond Air Inc (XAIR) Q3 2026 Earnings Call Highlights: Impressive Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Beyond Air Inc (XAIR) Q3 2026 Earnings Call Highlights: Impressi - GuruFocus
Balyasny Asset Management L.P. Increases Stake in Beyond Air Inc - GuruFocus
Beyond Air comments on review of high-dose nitric oxide therapy - Investing.com Nigeria
Beyond Air (XAIR) Highlights Potential of High-Dose Inhaled Nitr - GuruFocus
Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections - The Manila Times
Beyond Air, Inc. Highlights Comprehensive Review on High-Dose Inhaled Nitric Oxide as Potential Antimicrobial Therapy for Respiratory Infections - Quiver Quantitative
Beyond Air Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections - Bitget
High-dose inhaled gas shows promise against tough lung infections - Stock Titan
Published on: 2026-02-18 22:24:05 - baoquankhu1.vn
Analysis Recap: Is Beyond Air Inc showing insider buyingBuy Signal & AI Driven Stock Reports - baoquankhu1.vn
Aug Outlook: How liquid is Beyond Air Inc stockTrade Entry Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
XAIR Technical Analysis & ETF Price Forecast - Intellectia AI
Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket - Intellectia AI
MSN Money - MSN
Leishen Energy's FY2025 Financial Results Analysis - Intellectia AI
Analyst Warns: Failure of NeuroNOS Acquisition Could Pressure Beyond Air’s Strategy, Finances, and Stock Price - TipRanks
1 Reason I'd Buy Intuitive Surgical Stock and Never Sell - AOL.com
Beyond Air, Inc. (NASDAQ:XAIR) Q3 2026 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Beyond Air Q3 2026 sees revenue growth and cost cuts - Investing.com Nigeria
XAIR Technical Analysis & Stock Price Forecast - Intellectia AI
XAIR Maintains Revenue Outlook for Fiscal Year Ending 2026 - GuruFocus
Beyond Air (XAIR) Reports Strong Q3 Revenue With Promising Growt - GuruFocus
Beyond Air Shares Rise Intraday After Q3 FY2026 Revenue More Than Doubles; Loss Narrows on Cost Cuts - AlphaStreet News
Beyond Air Reports Strong Q3 Growth and Funding Extension - TipRanks
Beyond Air, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
Beyond Air, Inc. SEC 10-Q Report - TradingView
XAIR: Quarterly revenue doubled and net loss narrowed, but additional funding is needed within a year - TradingView
Beyond Air XAIR Q3 2026 Earnings Call Transcript - The Globe and Mail
Beyond Air Inc (XAIR) 財務データ
収益
当期純利益
現金流量
EPS
2.21%
0.24%
大文字化:
|
ボリューム (24 時間):